Thierry Passeron, MD, PhD

Speaker Details
  • Presentation Title

    Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study

  • Presentation Summary

    The use of GP-SOD combined with NB-UVB could be a useful add-on in the treatment of vitiligo patients with excellent tolerability and safety.

  • Additional Authors

    Henri Montaudié, Eric Fontas

  • Disclosures

    The study was supported by Isocell®. The sponsor did not have any role in the design and conduct of the study, in the collection, analysis or interpretation of the data, neither in the preparation, review or approval of the manuscript; and in the decision to submit the manuscript for publication.

    None of the authors received any financial compensation and none report any conflict of interest.

Download Abstract

This abstract can be found in the 2021 VIS Invited and Oral Speakers Abstract book